Abstract
The authors wish to note that the following statement should have been included in the Acknowledgments: This research has been supported (not financially) by European Reference Network for Rare Kidney Disease, ERKNet. This ERN is partly cofunded by the European Union within the framework of the Third Health Programme “ERN-2016–Framework Partnership Agreement 2017–2021.”
| Original language | English |
|---|---|
| Pages (from-to) | 510 |
| Number of pages | 1 |
| Journal | Clinical Journal of the American Society of Nephrology |
| Volume | 18 |
| Issue number | 4 |
| DOIs |
|
| Publication status | Published - 2023 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Correction: Guidelines for Genetic Testing and Management of Alport Syndrome (Clin J Am Soc Nephrol. 2022;17(1):143–154. doi:10.2215/CJN.04230321)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver